Depression trials in Brazil
10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Where
- Belo Horizonte, Curitiba, Marília, Maringá, Natal, Rio de Janeiro, São Bernardo do Campo, São Paulo, Valinhos
- Age
- 18 years to 75 years
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07412756 · EU 2025-522308-25-00 - Phase 3Taking peoplePhase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Where
- Brasília, Campinas, Criciúma, Natal, Passo Fundo, Porto Alegre, Rio de Janeiro, São Bernardo do Campo, São Paulo
- Age
- 18 years to 74 years
- People
- 752 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06559306 · EU 2023-509070-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Where
- Criciúma, Natal, Salvador, São Bernardo do Campo, São Paulo
- Age
- 12 years to 17 years
- People
- 258 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07227454 · EU 2024-518615-19-00 - Phase 3Taking peopleA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Where
- Salvador, São Bernardo do Campo, São Paulo
- Age
- 18 years to 74 years
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07573176 - Phase 3Taking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Where
- Campinas, Curitiba, Joinville, Passo Fundo, Recife, São Bernardo do Campo, São José do Rio Preto, São Paulo, Vitória, Votuporanga
- Age
- 18 years to 75 years
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07775300 · EU 2025-522310-24-00 - Phase 2Taking peopleInhaled DMT for Major Depressive Disorder
- Where
- Fortaleza, Natal, Rio de Janeiro, Salvador, São Paulo
- Age
- 18 years and over
- People
- 140
- Run by
- Universidade Federal do Rio Grande do Norte
See details and how to joinNCT07562191 - Phase 1/2Taking peopleCannabidiol Oil for Treatment-Resistant Major Depression
- Where
- Tubarão
- Age
- 18 years to 69 years
- People
- 120
- Run by
- Universidade do Sul de Santa Catarina
See details and how to joinNCT07696871 - Phase 2Not yet taking people in BrazilTriple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
- Where
- Porto Alegre
- Age
- 18 years to 65 years
- People
- 32
- Run by
- Hospital de Clinicas de Porto Alegre
See details and how to joinNCT07052058 - Phase 1/2Taking peoplePsilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
- Where
- Foz do Iguaçu
- Age
- 25 years to 65 years
- People
- 24
- Run by
- Federal University of Latin American Integration
See details and how to joinNCT06898606 - No phaseTaking peoplePsychoeducational Group for Depression
- Where
- São Paulo
- Age
- 18 years to 59 years
- People
- 338
- Run by
- Ricardo Alberto Moreno, M.D., Ph.D.
See details and how to joinNCT06467474